Focal Cortical Dysplasia Clinical Trials

11 clinical trials for Focal Cortical Dysplasia across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME) — RECRUITING · PHASE1
• Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue) — RECRUITING · NA
• A MULTICENTER, OPEN-LABEL STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFECT ON SEIZURES AND BEHAVIORAL SYMPTOMS OF RADIPRODIL IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC) OR FOCAL CORTICAL DYSPLASIA (FCD) TYPE II — RECRUITING
• Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II — ACTIVE_NOT_RECRUITING · PHASE1
• Study to Evaluate the Pharmacokinetics and Safety Effects Following Coadministration of Carbamazepine or Itraconazole With Radiprodil in Healthy Adults — TERMINATED · PHASE1
• Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs. — COMPLETED · PHASE1
• First-in-human Experience Using Novel Ultraflexible Low-impedance Electrode Arrays: an IDEAL Stage 1 Study — OTHER · NA
• Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery — WITHDRAWN · NA
• A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD — COMPLETED · PHASE2
• Study of Predictive Biomarkers for Rational Management of Drug-resistant Epilepsy Associated With Focal Cortical Dysplasia — OTHER
• Determining the Extent of Diffusion Tensor Abnormalities in Focal Cortical Dysplasia — COMPLETED

Refine this search